330 related articles for article (PubMed ID: 14669304)
1. Aberrant crypt foci as microscopic precursors of colorectal cancer.
Cheng L; Lai MD
World J Gastroenterol; 2003 Dec; 9(12):2642-9. PubMed ID: 14669304
[TBL] [Abstract][Full Text] [Related]
2. Aberrant crypt foci.
Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
4. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
6. CpG island methylation in aberrant crypt foci of the colorectum.
Chan AO; Broaddus RR; Houlihan PS; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2002 May; 160(5):1823-30. PubMed ID: 12000733
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
[TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
9. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
10. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
11. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin expression is altered in human colonic aberrant crypt foci.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability in aberrant crypt foci from human colons.
Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
15. K-ras and p53 mutations in human colorectal aberrant crypt foci.
Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
[TBL] [Abstract][Full Text] [Related]
17. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
[TBL] [Abstract][Full Text] [Related]
18. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
Nucci MR; Robinson CR; Longo P; Campbell P; Hamilton SR
Hum Pathol; 1997 Dec; 28(12):1396-407. PubMed ID: 9416697
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
